The German Biotechnology Sector 2015
More revenue, more jobs, more funding – all signs are pointing towards growth in the German biotech sector. These are the central conclusions of the company survey carried out by the information platform biotechnologie.de at the beginning of 2015 on behalf of the Federal Ministry of Education and Research (BMBF). In 2014, the turnover exceeded the milestone of 3 billion euros for the very first time. For the first time since 2008, spending on research and development (R&D) has increased once again.
The German Biotechnology Sector 2015
More revenue, more jobs, more funding – all signs are pointing towards growth in the German biotech sector. Never before have biotech companies generated as much revenue and employed as many people as now. In addition, interest from big business in biotech products remains steady, not only in the healthcare industry but also in the area of the bioeconomy. The number of employees in dedicated biotechnology companies jumped to 17,930 (+5.8%). The total number of these companies increased to 579 (+1.6%). A total of 14 start-ups were founded, which is almost the same amount as the year before (13).
In addition, there were 131 firms that were active in biotechnology, but as only one aspect of their business (2013: 130). A total of 19,200 people worked in the biotechnology-related areas of these companies (+4.1%). Thus, in the year 2014, there were 37,130 jobs places in commercial biotechnology in Germany. The financing situation has undergone a positive development, with around €445m capital raised (+10.2%). These are the central conclusions of the company survey carried out by the information platform biotechnologie.de at the beginning of 2015 on behalf of the Federal Ministry of Education and Research (BMBF). The data was gathered in accordance with the guidelines of the Organisation for Economic Cooperation and Development (OECD; for more methodology).